Production (Stage)
Intensity Therapeutics, Inc.
INTS
$0.4999
$0.03697.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.35M | -3.18M | -3.51M | -4.97M | -4.60M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 441.00K | 876.00K | 515.00K | 597.00K | 1.16M |
| Change in Net Operating Assets | 917.00K | -363.00K | -974.00K | 160.00K | -924.00K |
| Cash from Operations | -1.99M | -2.67M | -3.97M | -4.21M | -4.37M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 3.10M | -6.00K | 3.26M |
| Cash from Investing | -- | 0.00 | 3.10M | -6.00K | 3.26M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 345.00K | 3.05M | 495.00K | 3.00K | 8.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -17.00K | -571.00K | -82.00K | -- | -- |
| Cash from Financing | 328.00K | 2.48M | 413.00K | 3.00K | 8.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.66M | -192.00K | -459.00K | -4.22M | -1.10M |